RLAY
Relay Therapeutics Inc
18.00$
-4.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +1.5% | -1.9% | -740.9% | – | -9.4% | -132.5% | – | -134.5% | – | -28.6% | – | |
| – | -11.8% | +41.1% | -1.3% | -16.2% | -21.6% | +9.6% | -25.0% | +7.1% | -15.8% | -19.4% | -12.9% | – | |
| – | – | – | +61.0% | -262.1% | – | -1,140.8% | – | – | – | – | +73.5% | – | |
| – | -80.0% | +1,408.5% | -99.4% | +1,963.6% | -100.0% | – | -93.2% | -96.2% | +0.0% | -100.0% | – | – | |
| – | -16.4% | -82.4% | +332.5% | -377.0% | – | +46.4% | +77.0% | -47.1% | -10.7% | -7.2% | -1,173.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +131.7% | +123.2% | -96.8% | +14,095.1% | -99.6% | -100.0% | – | -97.4% | +5,394.1% | +14,758.9% | +133.3% | – | |
| – | -239.9% | – | -305.3% | – | -259.1% | – | – | -209.0% | – | – | -169.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.